arrow
J

Johan Maertens

university hospital gasthuisberg
H指数:96
被引数:5.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Treatment and outcome of chronic disseminated candidiasis in the era of antifungal prophylaxis: a retrospective multicentre cohort of 111 patients

抗真菌预防时代慢性播散性念珠菌病的治疗与预后:一项包含111例患者的回顾性多中心队列研究

2026-09-010
OAAI
Autologous stem cell transplantation versus consolidation chemotherapy as postremission treatment in newly diagnosed favorable‐ and intermediate‐risk patients with AML: A comparative analysis of HOVON–SAKK–Nordic trials

自体干细胞移植与巩固化疗作为新诊断的AML低危和中危患者的缓解后治疗:HOVON–SAKK–Nordic试验的比较分析

2026-08-210
OAAI
Prognostic value of measurable residual disease in high-risk MDS after intensive chemotherapy in HOVON-SAKK studies

高危MDS患者经强化疗后可测量残留疾病的预后价值:HOVON-SAKK研究

2026-05-210
OAAI
Outcomes of 544 Patients with t(6;9)/DEK::NUP214 acute myeloid leukemia undergoing allogeneic stem cell transplantation: an EBMT study on behalf of the acute leukemia working party (ALWP) and the pediatric diseases working party (PDWP)

544例t(6;9)/DEK::NUP214急性髓系白血病患者行异基因干细胞移植的结局:欧洲血液和骨髓移植组急性白血病工作组(ALWP)和儿科疾病工作组(PDWP)的代表性研究

2026-04-220
PRE
Hematopoietic stem cell transplantation is effective in achieving long-term survival for post-aplastic anemia myeloid neoplasms: the EBMT Severe Aplastic Anemia Report

造血干细胞移植对于实现再生障碍性贫血后髓系肿瘤的长期生存有效:欧洲血液和骨髓移植学会严重再生障碍性贫血报告

2026-01-010
OA
Frequency and impact of somatic co-occurring mutations on post-transplant outcomes in acute myeloid leukemia: a multicenter registry analysis on behalf of the EBMT ALWP

体细胞共发生突变在急性髓系白血病移植后结局中的频率和影响:一项代表EBMT ALWP的多中心登记研究

2025-12-050
PRE
TET2 mutation does not impact the prognosis of adult acute myeloid leukemia patients receiving a hematopoietic stem cell transplantation in first remission: similar outcome following matched sibling and unrelated versus haploidentical donor transplants in amulti-center retrospective analysis from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

TET2突变不影响接受造血干细胞移植且处于首次缓解期的成人急性髓系白血病患者的预后:欧洲血液与骨髓移植学会全球委员会和急性白血病工作组的多中心回顾性分析显示,配型相合的同胞或无关供者移植与单倍型相合供者移植后的结果相似。

2025-12-010
OAAI
Non-T-Depleted Haploidentical Transplantation Compared to Allogeneic Transplantation From Matched Siblings or Unrelated Donors in Patients With Secondary AML in First Complete Remission: A Study From the ALWP/EBMT

与来自相合同胞或无关供者的异基因移植相比,非T细胞耗竭的半相合移植在二次急性髓系白血病首次完全缓解期患者中的应用:一项来自ALWP/EBMT的研究

2025-12-010
OAAI
Different features of acute myeloid leukemia stem cell quantification in intensively treated patients

高强度治疗患者中急性髓系白血病干细胞定量测定的不同特征。Haematologica

2025-12-012
OA
Total-body irradiation-based versus chemotherapy alone as myeloablative conditioning regimen prior to hematopoietic allogeneic stem cell transplantation in adults with acute lymphoblastic leukemia: a multi-institutional study from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)

全身照射为基础与单纯化疗作为成人急性淋巴细胞白血病患者造血同种异基因干细胞移植前骨髓清除性预处理方案:一项来自法语区骨髓移植与细胞治疗学会(SFGM-TC)的多中心研究

2025-10-220
PRE
Impact of Wilms’ tumor 1 gene (WT1) mutation on outcome of allogeneic hematopoietic-cell transplantation for acute myeloid leukemia: a retrospective multicenter cohort study from the ALWP/EBMT registry

WT1基因突变对急性髓系白血病异基因造血细胞移植结局的影响:一项来自ALWP/EBMT注册中心的回顾性多中心队列研究

2025-10-160
OA
Improved GVHD-free relapse-free survival when rATG/ATLG is used in allo-HCT from matched sibling donors - an EBMT registry study by the Transplant Complications Working Party

使用rATG/ATLG时,匹配同胞供者 allo-HCT 的无GVHD无复发生存率得到改善——EBMT移植并发症工作组登记研究

2025-09-110
PRE
Computational measurable residual disease assessment in acute myeloid leukemia: a retrospective validation in the HOVON-SAKK-132 trial

急性髓系白血病中的计算性微小残留病评估:一项在HOVON-SAKK-132试验中的回顾性验证

Leukemia
IF13.4
2025-09-030
OAAI
Conditioning intensity in myelodysplastic patients aged ≥ 50 years undergoing allogeneic hematopoietic cell transplantation (allo-HCT): a study on behalf of the chronic malignancies working party of the EBMT

Conditioning强度在年龄≥50岁接受异基因造血细胞移植(allo-HCT)的骨髓增生异常综合征患者中的研究:代表EBMT慢性恶性疾病工作组的研究

2025-08-290
OAAI
Author’s Reply to the correspondence: ECIL-10 guidelines for COVID-19 should take convalescent plasma into proper consideration by Focosi et al.

作者对来函的回复:ECIL-10关于COVID-19的指南应适当考虑康复血浆的应用(Focosi等人)

Leukemia
IF13.4
2025-08-040
PRE
Older matched sibling donor versus young haplo-identical donor for elderly patients with acute myeloid leukemia

老年匹配同胞供者与年轻半相合供者用于老年急性髓系白血病患者

2025-07-180
OAAI